<DOC>
	<DOCNO>NCT02662972</DOCNO>
	<brief_summary>Trigeminal neuralgia one strong pain know human . Some patient enough effect available pharmaceutical treatment offer surgery . There different type procedure complex risk complication . The researcher want start pilot study 10 patient new surgical technique use neuronavigation . The target neural structure ( sphenopalatine ganglion ) important role facial pain . There trial try block structure trigeminal neuralgia , none use new approach botulinum toxin . The researcher technique require local anesthesia ( awake patient ) . The researcher believe treatment become `` low threshold '' -treatment patient enough effect pharmacological treatment well alternative complex surgical approach . Using new neuronavigation system researcher reach neural structure high precision .</brief_summary>
	<brief_title>Botulinum Toxin Type A Block Sphenopalatine Ganglion Trigeminal Neuralgia . Safety Issues .</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Ganglion Cysts</mesh_term>
	<mesh_term>Synovial Cyst</mesh_term>
	<mesh_term>Trigeminal Neuralgia</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Informed write consent Trigeminal neuralgia define International Classification Headache Disorders ( ICHD ) 3 criterion Unsatisfactory effect pharmacological treatment Microvascular decompression see well alternative Heart lung disease Any kind systematic local disease illness may significantly increase risk complication procedure relate injection Psychiatric illness hinders participation study Known pregnancy breast feed Inadequate use contraceptive Overuse abuse opioids Abuse medication , narcotic alcohol Anomalies hinder impede use method injection Allergy hypersensitivity reaction marcain , lidocaine , xylocain adrenalin , botulinum toxin type A , Botox 's constituent related medication Treatment medication interact botulinum toxin type A</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Nerve block</keyword>
	<keyword>Sphenopalatine Ganglion Block</keyword>
	<keyword>Botulinum Toxins , Type A</keyword>
</DOC>